Pharmacology and Toxicology
Showing page 9 of 22 pages of list content
-
The Petasites hybridus CO2-extract (Ze 339) blocks SARS-CoV-2 replication in vitro
This article's authors -
Remodeling of dermal adipose tissue alleviates cutaneous toxicity induced by anti-EGFR therapy
This article's authors -
Drug repurposing screening identified tropifexor as a SARS-CoV-2 papain-like protease inhibitor
This article's authors -
Atazanavir is a competitive inhibitor of SARS-CoV-2 Mpro, impairing variants replication in vitro and in vivo
This article's authors -
Hypertonic saline and aprotinin based blockage of SARS-CoV-2 specific furin site cleavage by inhibition of nasal protease activity
This article's authors -
Dual Effects of Nanoviricides Platform Technology Based NV-CoV-2 Biomimetic Polymer Against COVID-19
This article's authors -
Nanoviricide’s platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo
This article's authors -
Validation and invalidation of SARS-CoV-2 papain-like protease inhibitors
This article's authors -
Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell
This article's authors -
Novel pectin from crude polysaccharide of Syzygium aromaticum against SARS-CoV-2 activities by targeting 3CLpro
This article's authors